These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1053 related articles for article (PubMed ID: 33969504)

  • 1. SARS-CoV-2 B.1.1.7 reinfection after previous COVID-19 in two immunocompetent Italian patients.
    Novazzi F; Baj A; Genoni A; Spezia PG; Colombo A; Cassani G; Zago C; Pasciuta R; Della Gasperina D; Ageno W; Severgnini P; Dentali F; Focosi D; Maggi F
    J Med Virol; 2021 Sep; 93(9):5648-5649. PubMed ID: 33969504
    [No Abstract]   [Full Text] [Related]  

  • 2. Sensitive Immunodetection of Severe Acute Respiratory Syndrome Coronavirus 2 Variants of Concern 501Y.V2 and 501Y.V1.
    Barlev-Gross M; Weiss S; Paran N; Yahalom-Ronen Y; Israeli O; Nemet I; Kliker L; Zuckerman N; Glinert I; Noy-Porat T; Alcalay R; Rosenfeld R; Levy H; Mazor O; Mandelboim M; Mendelson E; Beth-Din A; Israely T; Mechaly A
    J Infect Dis; 2021 Aug; 224(4):616-619. PubMed ID: 34398244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imported SARS-CoV-2 Variant P.1 in Traveler Returning from Brazil to Italy.
    Maggi F; Novazzi F; Genoni A; Baj A; Spezia PG; Focosi D; Zago C; Colombo A; Cassani G; Pasciuta R; Tamborini A; Rossi A; Prestia M; Capuano R; Azzi L; Donadini A; Catanoso G; Grossi PA; Maffioli L; Bonelli G
    Emerg Infect Dis; 2021 Apr; 27(4):1249-1251. PubMed ID: 33567246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early assessment of diffusion and possible expansion of SARS-CoV-2 Lineage 20I/501Y.V1 (B.1.1.7, variant of concern 202012/01) in France, January to March 2021.
    Gaymard A; Bosetti P; Feri A; Destras G; Enouf V; Andronico A; Burrel S; Behillil S; Sauvage C; Bal A; Morfin F; Van Der Werf S; Josset L; ; ; Blanquart F; Coignard B; Cauchemez S; Lina B
    Euro Surveill; 2021 Mar; 26(9):. PubMed ID: 33663644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Introduction of SARS-CoV-2 variant of concern 20h/501Y.V2 (B.1.351) from Malawi to Italy.
    Novazzi F; Genoni A; Spezia PG; Focosi D; Zago C; Colombo A; Cassani G; Pasciuta R; Tamborini A; Rossi A; Prestia M; Capuano R; Gasperina DD; Dentali F; Severgnini P; Ageno W; Gambarini C; Stefanelli P; Baj A; Maggi F
    Emerg Microbes Infect; 2021 Dec; 10(1):710-712. PubMed ID: 33739917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The basis of a more contagious 501Y.V1 variant of SARS-CoV-2.
    Liu H; Zhang Q; Wei P; Chen Z; Aviszus K; Yang J; Downing W; Jiang C; Liang B; Reynoso L; Downey GP; Frankel SK; Kappler J; Marrack P; Zhang G
    Cell Res; 2021 Jun; 31(6):720-722. PubMed ID: 33893398
    [No Abstract]   [Full Text] [Related]  

  • 7. First detection of SARS-CoV-2 spike protein N501 mutation in Italy in August, 2020.
    Fiorentini S; Messali S; Zani A; Caccuri F; Giovanetti M; Ciccozzi M; Caruso A
    Lancet Infect Dis; 2021 Jun; 21(6):e147. PubMed ID: 33450180
    [No Abstract]   [Full Text] [Related]  

  • 8. SARS-CoV-2 reinfection in a healthcare professional in inner Sao Paulo during the first wave of COVID-19 in Brazil.
    Camargo CH; Gonçalves CR; Pagnoca EVRG; Campos KR; Montanha JOM; Flores MNP; Soares MMCN; Binhardi FMT; Ferreira PM; Yu ALF; Carvalhanas TRMP; Abbud A; Bugno A; Sacchi CT
    Diagn Microbiol Infect Dis; 2021 Dec; 101(4):115516. PubMed ID: 34425504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of a Lineage C.36 SARS-CoV-2 Isolate with Reduced Susceptibility to Neutralization Circulating in Lombardy, Italy.
    Castelli M; Baj A; Criscuolo E; Ferrarese R; Diotti RA; Sampaolo M; Novazzi F; Dalla Gasperina D; Focosi D; Ferrari D; Locatelli M; Clementi M; Clementi N; Maggi F; Mancini N
    Viruses; 2021 Jul; 13(8):. PubMed ID: 34452380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First Identified Cases of SARS-CoV-2 Variant B.1.1.7 in Minnesota - December 2020-January 2021.
    Firestone MJ; Lorentz AJ; Wang X; Como-Sabetti K; Vetter S; Smith K; Holzbauer S; Meyer S; Ehresmann K; Danila R; Lynfield R
    MMWR Morb Mortal Wkly Rep; 2021 Feb; 70(8):278-279. PubMed ID: 33630825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Omicron (B.1.1.529) - variant of concern - molecular profile and epidemiology: a mini review.
    Kannan S; Shaik Syed Ali P; Sheeza A
    Eur Rev Med Pharmacol Sci; 2021 Dec; 25(24):8019-8022. PubMed ID: 34982466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of a Novel SARS-CoV-2 Genetic Variant with Distinct Spike Protein Mutations.
    Gladkikh A; Dolgova A; Dedkov V; Sbarzaglia V; Kanaeva O; Popova A; Totolian A
    Viruses; 2021 May; 13(6):. PubMed ID: 34072569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Symptomatic reinfection of SARS-CoV-2 with spike protein variant N440K associated with immune escape.
    Rani PR; Imran M; Lakshmi JV; Jolly B; Jain A; Surekha A; Senthivel V; Chandrasekhar P; Divakar MK; Srinivasulu D; Bhoyar RC; Vanaja PR; Scaria V; Sivasubbu S
    J Med Virol; 2021 Jul; 93(7):4163-4165. PubMed ID: 33818797
    [No Abstract]   [Full Text] [Related]  

  • 14. Genomic Evidence of SARS-CoV-2 Reinfection Involving E484K Spike Mutation, Brazil.
    Nonaka CKV; Franco MM; Gräf T; de Lorenzo Barcia CA; de Ávila Mendonça RN; de Sousa KAF; Neiva LMC; Fosenca V; Mendes AVA; de Aguiar RS; Giovanetti M; de Freitas Souza BS
    Emerg Infect Dis; 2021 May; 27(5):1522-1524. PubMed ID: 33605869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Real-Time RT-PCR Allelic Discrimination Assay for Detection of N501Y Mutation in the Spike Protein of SARS-CoV-2 Associated with B.1.1.7 Variant of Concern.
    Abdulnoor M; Eshaghi A; Perusini SJ; Broukhanski G; Corbeil A; Cronin K; Fittipaldi N; Forbes JD; Guthrie JL; Kus JV; Li Y; Majury A; Mallo GV; Mazzulli T; Melano RG; Olsha R; Sullivan A; Tran V; Patel SN; Allen VG; Gubbay JB
    Microbiol Spectr; 2022 Feb; 10(1):e0068121. PubMed ID: 35170989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of Three Mutations in Italian Strains of SARS-CoV-2: Implications for Pathogenesis.
    Benvenuto D; Benedetti F; Demir AB; Ciccozzi M; Zella D
    Chemotherapy; 2021; 66(1-2):33-37. PubMed ID: 33735872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Replicative Fitness of a SARS-CoV-2 20I/501Y.V1 Variant from Lineage B.1.1.7 in Human Reconstituted Bronchial Epithelium.
    Touret F; Luciani L; Baronti C; Cochin M; Driouich JS; Gilles M; Thirion L; Nougairède A; de Lamballerie X
    mBio; 2021 Aug; 12(4):e0085021. PubMed ID: 34225487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2 reinfection with a virus harboring mutation in the Spike and the Nucleocapsid proteins in Panama.
    Díaz Y; Ortiz A; Weeden A; Castillo D; González C; Moreno B; Martínez-Montero M; Castillo M; Vasquez G; Sáenz L; Franco D; Pitti Y; Chavarria O; Gondola J; Moreno AM; Ábrego L; Beltrán D; Guerra I; Chang J; Chaverra Z; Guerrero I; Valoy A; Gaitán M; Araúz D; Morán E; Chen-Germán M; Valdespino E; Rodríguez R; Corrales R; Chen-Camaño R; Pascale JM; Martínez AA; López-Vergès S;
    Int J Infect Dis; 2021 Jul; 108():588-591. PubMed ID: 34107326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First Detection of SARS-CoV-2 B.1.1.7 Variant of Concern in an Asymptomatic Dog in Spain.
    Barroso-Arévalo S; Rivera B; Domínguez L; Sánchez-Vizcaíno JM
    Viruses; 2021 Jul; 13(7):. PubMed ID: 34372585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Re-emergence of Gamma-like-II and emergence of Gamma-S:E661D SARS-CoV-2 lineages in the south of Brazil after the 2021 outbreak.
    Oliveira MM; Schemberger MO; Suzukawa AA; Riediger IN; do Carmo Debur M; Becker G; Resende PC; Gräf T; Balsanelli E; de Baura VA; de Souza EM; Pedrosa FO; Alves LR; Blanes L; Nardelli SC; Aguiar AM; Albrecht L; Zanette D; Ávila AR; Morello LG; Marchini FK; Dos Santos HG; Passetti F; Dallagiovanna B; Faoro H
    Virol J; 2021 Nov; 18(1):222. PubMed ID: 34789293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 53.